Deep Brain Stimulation Devices Market Size by Application, Type, Regional,
Industry Statistics & Forecast 2021 – 2025
Global Deep Brain Stimulation Devices market Size by Type, End User and Application: Global
Opportunity Analysis and Industry Forecast, 2020-2025. The base year considered for the study is
2020, and the forecast has been provided for the period from 2020 to 2025.
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical
device called a neurostimulator (sometimes referred to as a brain pacemaker), which sends
electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for
the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has
provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinsons
disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive
disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still
not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible
(unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow
North America is the largest sales place, with a sales market share nearly 51% in 2019. Following
North America, Europe is the second largest sales place with the sales market share of 30%. China,
Japan is also important sales regions for Deep Brain Stimulation Devices.
Deep Brain Stimulation Device market is mainly occupied by large companies, Sorin as the largest
player in the market produced over 57% of Artificial Heart Lung Machine and made more than
59.6% of revenue share in 2019. MAQUET followed as second produced about 18.3% in 2019.
Through the above research we tend to believe that Medtronic is the most important player in the
market and it will occupy a major share of the market with about 70%. The competition will